CytomX Therapeutics (CTMX) Goodwill (2014 - 2026)

CytomX Therapeutics (CTMX) reported Goodwill of $949000.0 for Q1 2026, little changed on a YoY basis from $949000.0 in Q1 2025, and little changed quarter-over-quarter from $949000.0 in Q4 2025.

CytomX Therapeutics (CTMX) Goodwill (2014 - 2026) Analysis & Trends

CytomX Therapeutics has reported Goodwill for 13 years, with the latest figure at $949000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Goodwill changed 0.0% year-over-year to $949000.0; the trailing twelve-month figure through Mar 2026 stood at $949000.0 (changed 0.0% YoY), and the FY2025 full-year result was $949000.0, changed 0.0% from the prior year.
  • Goodwill for Q1 2026 stood at $949000.0, roughly flat from $949000.0 in the prior quarter.
  • The five-year high for Goodwill was $949000.0 in Q1 2022, with the low at $949000.0 in Q1 2022.
  • Historically, Goodwill has averaged $949000.0 across 5 years, with a median of $949000.0 in 2022.
  • The largest YoY upside for Goodwill was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
  • CytomX Therapeutics' Goodwill stood at $949000.0 in 2022, then changed by 0.0% to $949000.0 in 2023, then changed by 0.0% to $949000.0 in 2024, then changed by 0.0% to $949000.0 in 2025, then changed by 0.0% to $949000.0 in 2026.
  • The last three Goodwill figures came in at $949000.0 (Q1 2026), $949000.0 (Q4 2025), and $949000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 CytomX Therapeutics 520.30 Mn 173.59 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 949,000.00
Dec 31, 2025 949,000.00
Sep 30, 2025 949,000.00
Jun 30, 2025 949,000.00
Mar 31, 2025 949,000.00
Dec 31, 2024 949,000.00
Sep 30, 2024 949,000.00
Jun 30, 2024 949,000.00
Mar 31, 2024 949,000.00
Dec 31, 2023 949,000.00
Sep 30, 2023 949,000.00
Jun 30, 2023 949,000.00
Mar 31, 2023 949,000.00
Dec 31, 2022 949,000.00
Sep 30, 2022 949,000.00
Jun 30, 2022 949,000.00
Mar 31, 2022 949,000.00
Dec 31, 2021 949,000.00
Sep 30, 2021 949,000.00
Jun 30, 2021 949,000.00